Loading clinical trials...
Loading clinical trials...
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion: a Randomized Controlled Trial
Conditions
Interventions
Cabergoline
Placebo
Locations
1
United States
Northwestern Medical Center
Chicago, Illinois, United States
Start Date
December 18, 2023
Primary Completion Date
June 30, 2024
Completion Date
June 30, 2024
Last Updated
May 29, 2024
NCT07487246
NCT06029673
NCT06078501
NCT06164067
NCT04038749
NCT03400358
Lead Sponsor
Northwestern University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions